| URL | https://www.drovers.com/article/boehringer-ingelhe |
| Source | Drovers |
| Date Published | 12/04/2017 |
| Author Name | Sara Brown |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Boehringer Ingelheim Vetmedica Inc. |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2017 |
| Year reshoring implemented or to be implemented: | 2019 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 40 |
| Country(ies) from which reshored: | Germany |
| City reshored to: | Athens |
| State(s) reshored to: | GA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | animal and avian vaccines |